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Abstract
Direct-acting antivirals (DAAs) are revolutionizing the treatment of hepatitis C virus
(HCV) infection. Yet, our understanding of the impact of DAAs, how HCV population
responds to drug pressure and the mechanism of resistance development remains
incomplete. Previous theory in general assumed resistant viruses arise through
infection of newly generated cells. Here we take longitudinal clinical samples from
five patients who were treated with an HCV protease inhibitor once daily for 7 days.
Measurement of viral load and single genome sequencing of viral population reveal
extremely rapid resistance development and surprising turnover of dominant
resistant mutants over 7 weeks’ period after treatment. Developing evolutionary
models to simultaneously describe the viral load and viral sequence data, we show
that predictions of previous theory with realistic biological parameters are
inconsistent with data. Incorporating cure and superinfection of already infected
cells reconciles model prediction with the extremely rapid resistant development
and mutant turnovers, suggesting their important roles in accelerating within-host
resistant evolution. Further, we find that the stability of resistant mutants in the
viral population long after treatment cessation is likely to be due to compensatory
mutations, highlighting the risk of resistant mutant transmission, especially when
treatment is interrupted or after treatment failure.

